Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.4810.8513.9019.8526.93

What is the latest EV/Core EBITDA ratio of BIOCON ?

The latest EV/Core EBITDA ratio of BIOCON is 12.48 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.48
Mar202410.85
Mar202313.90
Mar202219.85
Mar202126.93

How is EV/Core EBITDA of BIOCON Trending?

Years EV/Core EBITDA % Change
Mar2025 12.48
15.02
Mar2024 10.85
-21.94
Mar2023 13.9
-29.97
Mar2022 19.85
-26.29
Mar2021 26.93 -

Other Financial Ratios of BIOCON


Compare EV/Core EBITDA ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹63,288.0 Cr -1.9% 3.9% 21.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹106,768.0 Cr -2.3% 0.3% -8.9% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.9%

3.9%

21.2%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses